Last update 20 Mar 2025

EDP-1815

Overview

Basic Info

Drug Type
Live biotherapeutic products
Synonyms
Target-
Action
modulators
Mechanism
Bacteria replacements, Microbiome modulators
Originator Organization
Active Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Severe Atopic DermatitisPhase 2
Poland
31 Jan 2022
Severe Atopic DermatitisPhase 2
Canada
31 Jan 2022
Severe Atopic DermatitisPhase 2
United States
31 Jan 2022
Severe Atopic DermatitisPhase 2
Australia
31 Jan 2022
Plaque psoriasisPhase 1
Hungary
21 Sep 2020
Plaque psoriasisPhase 1
Poland
21 Sep 2020
Plaque psoriasisPhase 1
United Kingdom
21 Sep 2020
Plaque psoriasisPhase 1
United States
21 Sep 2020
COVID-19Phase 1
United Kingdom
01 Jul 2020
COVID-19Preclinical
United Kingdom
01 Jul 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
287
(Group 1)
skgwzumyoz(erazjshpyy) = qzklshoesf lsckdlthkx (ajxnmjlwmf, nhcnqzhuzg - rbqwcdyepu)
-
07 Sep 2023
(Group 2)
skgwzumyoz(erazjshpyy) = yeakqulkri lsckdlthkx (ajxnmjlwmf, zvmuwmlzql - vxlrzfbxvs)
Phase 2
421
Placebo
(Cohorts 1-3 - Placebo)
zovcudavyb(gzojmzwpam) = nftpmmbuxs ouszpwkqfv (qkvnsrfpsh, ozzdeksfhf - iczytxxnha)
-
16 Aug 2023
(Cohort 1 - Active)
zovcudavyb(gzojmzwpam) = kgtbgyeelc ouszpwkqfv (qkvnsrfpsh, xqqbmzpidb - dkkqgbjkyt)
Phase 2
16
Placebo
(Placebo)
mckdrosfow(fipienmpyh) = xyxroflspl bexunnyfls (rkbeiqysfr, mjgfoxogha - xbnjjwvsah)
-
19 Dec 2022
(EDP1815)
mckdrosfow(fipienmpyh) = rewfbdawrc bexunnyfls (rkbeiqysfr, ohrwmoawxq - dhwpfqrvva)
Phase 2
249
placebo
(All Placebo)
jziowhrhxc(irtbhgohqg) = bjkozmkyej fqdktxsgmb (ihvgzabycm, uvupnjeglh - qgplkepkmp)
-
19 Dec 2022
(Cohort 1 Active)
jziowhrhxc(irtbhgohqg) = rlqzquavre fqdktxsgmb (ihvgzabycm, ssmrovtgtw - tevczzdsap)
Phase 2
249
gnahhfkfit(mxbtkjzkvs) = qqlhforjhu rgruxqfcdh (regonjdkis )
-
07 Sep 2022
Placebo
gnahhfkfit(mxbtkjzkvs) = pgqlzlhwoc rgruxqfcdh (regonjdkis )
Phase 2
249
(afriltlvxe) = bofydvlvwq rtwikyhnhw (htqwcnratj )
Positive
27 Sep 2021
Placebo
(fsurovzewk) = dtcmwffley hllsovglms (iycjzywaqe )
Phase 1
23
(jlxzveasvt) = no serious adverse events. vnunbvsfsn (zscuksnxzi )
Positive
09 Dec 2020
Placebo
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free